US drug regulator clears Qnovia’s nicotine inhaler for clinical testing
HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.
Drugs
Health
Pharma
Health
Medical
Pharma
Quitting smoking at any age brings great benefits finds global study
HQ Team February 10, 2024: A study on smoking carried out by the University of Toronto says that people who quit smoking at.